Medication info
Baijetin Tablet 10/10

Baijetin Tablet 10/10

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Nexpharm Korea Co., Ltd.
Appearance
White to light yellow, bilaterally convex, rectangular tablet
Packaging
30 tablets/PTP (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201803869 · Approved 2018.09.28

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg once daily. The usual recommended starting dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of 4 weeks or more and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, subsection on patients with abnormal liver function). Use in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and closely monitor these patients when administering higher doses of this medicine (see Precautions for Use, 5. General Precautions). Use in elderly patients No dose adjustment is necessary in elderly patients. Concomitant use with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Nexpharm Korea Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular diseases due to hypercholesterolemia
  • dyslipidemia
  • diabetes
  • hypothyroidism
  • obstructive liver disease
  • chronic renal failure
View approved original text

This medication helps lower blood cholesterol and triglycerides in patients with primary hypercholesterolemia and mixed dyslipidemia, and increases good cholesterol, HDL. It can be used in combination with or as an alternative treatment for patients with familial hypercholesterolemia. Dietary control should also be implemented during treatment, and secondary causes such as diabetes or thyroid issues should be confirmed. Blood lipid levels need to be monitored closely, and further tests may be necessary to accurately ascertain the condition. This drug can be safely used alongside other treatments to help improve blood lipids.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg once daily. The usual recommended starting dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of 4 weeks or more and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, subsection on patients with abnormal liver function). Use in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and closely monitor these patients when administering higher doses of this medicine (see Precautions for Use, 5. General Precautions). Use in elderly patients No dose adjustment is necessary in elderly patients. Concomitant use with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This drug may cause serious muscular adverse reactions such as myopathy and rhabdomyolysis. The risk may be increased especially when taken at high doses or with certain medications, so caution is advised. Patients with allergies to any components of this medication, severely impaired liver function, those who are pregnant or breastfeeding should not take this medication. Additionally, when used in conjunction with certain antifungal agents, antibiotics, immunosuppressants, etc., the risk of muscle damage may increase, so it should be discussed with a doctor. If muscle pain, weakness, or unexplained muscle pain occurs, medical personnel must be informed immediately, and medication should be discontinued if necessary. Patients with liver dysfunction or a history of liver disease should have regular liver function tests before and during treatment with this medication. This drug may be harmful to the fetus during pregnancy, so women who are planning to become pregnant or may become pregnant must consult a doctor before taking it. It is also recommended to discontinue breastfeeding while taking this medication. Elderly patients or those with impaired kidney function should also exercise particular caution when taking this medication. In addition, this medication can elevate blood sugar levels, so patients at risk of diabetes should regularly check their blood glucose levels. When starting any new medication during the treatment with this medication, it is essential to inform medical personnel, and caution should be taken as there may be interactions with certain foods such as grapefruit juice.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory tract infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, paresthesia, depression, cholelithiasis, cholecystitis, mucocutaneous syndrome, toxic epidermal necrolysis, eosinophilia, drug reactions with systemic symptoms, erythema multiforme, liver damage, myasthenia, cataract, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, dysgeusia, ophthalmoplegia, facial weakness, tremor, peripheral neuropathy, peripheral nerve paralysis, mental disorder, anxiety, sleep disturbances, memory impairment, forgetfulness, amnesia, cognitive impairment, confusion, interstitial lung disease, lupus-like erythema, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibodies, increased erythrocyte sedimentation rate, arthritis, photosensitivity, fever, chills, flushing, malaise, dyspnea, cholestatic jaundice, liver fat changes, cirrhosis, fulminant hepatic necrosis, hepatocellular carcinoma, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, ophthalmoplegia, anemia, elevated aminotransferases, elevated ALP, elevated gamma-GT, increased bilirubin levels, thyroid dysfunction, elevated serum creatine kinase, transient liver function test abnormalities, increased HbA1c, elevated fasting blood sugar levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve its efficacy.

Appearance and packaging

Appearance

White to light yellow, bilaterally convex, rectangular tablet

Package unit

30 tablets/PTP (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.